Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH)

Authors :: G. Bera
Alexandre Coutte
Cedrik Lafond
Jessica Miroir
Laurent Gibel
Natacha Colin-Batailhou
Xu Shan Sun
Aline Maillard
Yungan Tao
Jean Bourhis
Laurent Martin
Joël Guigay
Anne Auperin
Christian Sire
Cécile Michel
Source :: Journal of Clinical Oncology. 36:6076-6076
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 6076Background: Based on the hypothesis of a synergistic effect of the anti-PDL1 avelumab when combined with cetuximab (cetux) and RT, this new combination is tested in a large scale randomized tri...

Tools